Inhibiting miR-205 Alleviates Cardiac Ischemia/Reperfusion Injury by Regulating Oxidative Stress, Mitochondrial

Yuerong Xu1,2, Wangang Guo1, Di Zeng1

  • 1Department of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.

Abstract

Insights

Inhibiting miR-205 protects the heart from ischemia/reperfusion injury by reducing apoptosis and oxidative stress. This protection is mediated by Rnd3, offering a potential therapeutic target for cardiac injury.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Cellular Biology

Background:

  • MicroRNA-205 (miR-205) plays a role in oxidative stress, mitochondrial dysfunction, and apoptosis.
  • The specific involvement of miR-205 in cardiac ischemia/reperfusion (I/R) injury is not well understood.

Purpose of the Study:

  • To investigate the regulatory role of miR-205 in cardiac I/R injury.
  • To elucidate the mechanisms involving oxidative stress, mitochondrial function, and apoptosis.

Main Methods:

  • Examined miR-205 and Rnd3 levels in I/R cardiac tissues.
  • Assessed myocardial infarct size, cardiac function, oxidative stress, mitochondrial function, and apoptosis in a mouse model of myocardial ischemia/reperfusion (MI/R) injury.
  • Utilized hypoxia/reoxygenation (H/R) in primary neonatal cardiomyocytes to simulate MI/R injury.

Main Results:

  • miR-205 levels were elevated, while Rnd3 levels were decreased in I/R cardiac tissues.
  • Inhibiting miR-205 reduced infarct size, apoptosis, oxidative stress, and mitochondrial dysfunction, while improving cardiac function.
  • Overexpression of miR-205 exacerbated MI/R injury.
  • Downregulation of miR-205 reduced oxidative stress in H/R-treated cardiomyocytes.
  • Inhibiting Rnd3 abolished the protective effects of miR-205 inhibition.

Conclusions:

  • Inhibiting miR-205 mitigates cardiac I/R injury by enhancing Rnd3, thereby suppressing oxidative stress, mitochondrial dysfunction, and apoptosis.
  • Targeting miR-205 inhibition and subsequent Rnd3 activation presents a viable therapeutic strategy for treating MI/R injury.